Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
주식 순위 #5706
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
주가
$5.21
시가총액
$2.49B
변동 (1일)
-0.91%
변동 (1년)
-34.46%
국가
CN
거래 Bloomage BioTechnology Corporation Limited (688363)

카테고리

Bloomage BioTechnology Corporation Limited (688363)의 EPS
2026 기준 EPS TTM: 0
Bloomage BioTechnology Corporation Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Bloomage BioTechnology Corporation Limited의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$15.56 -
GB
- -
FR
$10.95 -
US
$7.50 -
US
$-0.21 -
US